T1	Treatment 28 42	intra-arterial
T2	Treatment 50 69	intravenous heparin
T3	Treatment 386 393	heparin
T4	Treatment 484 691	randomized to an intravenous group (n = 250), receiving 50 U/kg of unfractionated heparin (maximal dose 5,000 U) intravenously, and an intra-arterial group (n = 250) receiving the same dose intra-arterially.
T5	Treatment 716 837	vasodilator "cocktail" intra-arterially and underwent cardiac catheterization using a 5F introducer sheath and catheters.
